1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Diastolic Heart Failure Global Clinical Trials Review, H1, 2015

Diastolic Heart Failure Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H1, 2015" provides data on the Diastolic Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diastolic Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diastolic Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Diastolic Heart Failure Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diastolic Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Diastolic Heart Failure 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Diastolic Heart Failure Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
Gilead Sciences, Inc. 33
Clinical Trial Overview of Gilead Sciences, Inc. 33
Synvista Therapeutics, Inc. 34
Clinical Trial Overview of Synvista Therapeutics, Inc. 34
Solvotrin Innovations Ltd 35
Clinical Trial Overview of Solvotrin Innovations Ltd 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Cardiovascular Clinical Studies, Inc. 37
Clinical Trial Overview of Cardiovascular Clinical Studies, Inc. 37
Bayer AG 38
Clinical Trial Overview of Bayer AG 38
A. Menarini Industrie Farmaceutiche Riunite Srl 39
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 39
Clinical Trial Overview of Top Institutes / Government 40
Baylor College of Medicine 40
Clinical Trial Overview of Baylor College of Medicine 40
Brigham and Women's Hospital 41
Clinical Trial Overview of Brigham and Women's Hospital 41
Duke University 42
Clinical Trial Overview of Duke University 42
St. Vincent's University Hospital 43
Clinical Trial Overview of St. Vincent's University Hospital 43
University of Michigan 44
Clinical Trial Overview of University of Michigan 44
University of Missouri 45
Clinical Trial Overview of University of Missouri 45
University of Wisconsin Madison 46
Clinical Trial Overview of University of Wisconsin Madison 46
Aarhus University 47
Clinical Trial Overview of Aarhus University 47
All India Institute of Medical Sciences 48
Clinical Trial Overview of All India Institute of Medical Sciences 48
Asan Medical Center 49
Clinical Trial Overview of Asan Medical Center 49
Five Key Clinical Profiles 50
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82

List of Tables
Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2015* 7
Diastolic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Diastolic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Diastolic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Diastolic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Diastolic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Diastolic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Diastolic Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Diastolic Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Diastolic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 32
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 33
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Synvista Therapeutics, Inc., 2015* 34
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Solvotrin Innovations Ltd, 2015* 35
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiovascular Clinical Studies, Inc., 2015* 37
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 38
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2015* 39
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 40
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015* 41
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 42
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Vincent's University Hospital, 2015* 43
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 44
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2015* 45
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015* 46
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 47
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 48
Diastolic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 49

List of Figures
Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Diastolic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Diastolic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Diastolic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Diastolic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Diastolic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Diastolic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Diastolic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.